The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sidorov A.V.

Federal State Budgetary Educational Institution of Higher Education «Yaroslavl State Medical University» of the Ministry of Healthcare of the Russian Federation, Yaroslavl, Russia

Polevichenko E.V.

Ulrikh G.E.

Nevzorova D.V.

Akhantyeva T.B.

Sukhanov Yu.V.

Padalkin V.P.

Sharshov F.G.

Pain relief in pediatric palliative care: the place of fentanyl transdermal therapeutic system (according to the materials of Advisory Board Meeting)

Authors:

Sidorov A.V., Polevichenko E.V., Ulrikh G.E., Nevzorova D.V., Akhantyeva T.B., Sukhanov Yu.V., Padalkin V.P., Sharshov F.G.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2018;7(5): 97‑103

Read: 2665 times


To cite this article:

Sidorov AV, Polevichenko EV, Ulrikh GE, et al. . Pain relief in pediatric palliative care: the place of fentanyl transdermal therapeutic system (according to the materials of Advisory Board Meeting). P.A. Herzen Journal of Oncology. 2018;7(5):97‑103. (In Russ.)
https://doi.org/10.17116/onkolog2018705197

References:

  1. Rekomendatsii VOZ po medikamentoznomu lecheniyu persistiruyushchei boli u detei s somaticheskimi zabolevaniyami. Prakticheskaya meditsina. 2014. (In Russ.)
  2. Model List of Essential Medicines for children (EMLc) Available at:http://www.who.int/medicines/publications/essentialmedicines/6th_EMLc2017_FINAL_amendedAug2017.pdf?ua=1. Accessed 04.07.2018
  3. Persisting pain in children package: WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. WHO; 2012.
  4. Kumirova EV. Formulyar lekarstvennykh sredstv v palliativnoi pediatrii. Moscow. 2016. (In Russ.)
  5. Instruktsiya po meditsinskomu primeneniyu preparata Fendiviya. (In Russ.)
  6. Marier JF, Lor M, Potvin D, Dimarco M, Morelli G, Saedder EA. Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects. J Clin Pharmacol. 2006;46(6):642-653. https://doi.org/10.1177/0091270006286901
  7. Marier JF. Comparative bioequivalence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation. Br J Clin Pharmacol. 2007;63:121-124. https://doi.org/10.1111/j.1365-2125.2006.02758.x
  8. Kress HG, Boss H, Delvin T, Lahu G, Lophaven S, Marx M, Skorjanec S, Wagner T. Transdermal fentanyl matrix patches Matrifen and Durogesic DT rans are bioequvivalent. Eur J Pharm Biopharm. 2010;75(2):225-231. https://doi.org/10.1016/j.ejpb.2010.02.005
  9. Finkel JC, Finley A, Greco C, Weisman SJ, Zeltzer L. Transdermal fentanyl in the management of children with chronic severe pain. Results from an International Study. Cancer. 2005;104(12):2847-2857. https://doi.org/10.1002/cncr.21497
  10. Matrifen SmPS. Available at: https://www.medicines.org.uk/emc/product/288/smpc#
  11. Mercadante S, Porzio G, Ferrera P, Aielli F, Adile C, Ficorella C. Low doses of transdermal fentanyl in opioid-naive patients with cancer pain. Curr Med Res Opin. 2010;26(12):2765-2768. https://doi.org/10.1185/03007995.2010.532545
  12. Othman AH, Mohamad FM, Sayed HA-R. Transdermal fentanyl for cancer pain management in opioid-naive pediatric cancer patients. Pain Med. 2016 Feb 25;pii: pnw004. https://doi.org/10.1093/pm/pnw004
  13. Ziesenitz VC, Vaughns JD, Koch G, Mikus G, van den Anker JN. Correction to: Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review. Clin Pharmacokinet. 2018;57:393-417. https://doi.org/10.1007/s40262-017-0609-2
  14. Rosaeg OP, Kitts JB, Koren G, Byford LJ. Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic parturient. Can J Anaesth.1992;39(3):277-281. https://doi.org/10.1007/BF03008789
  15. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med. 2002;347(14):1094-1103. https://doi.org/10.1056/NEJMra012626
  16. Lötsch J, Walter C, Parnham MJ, Oertel BG, Geisslinger G. Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet. 2013;52(1):23-36. https://doi.org/10.1007/s40262-012-0016-7
  17. Zernikow B, Michel E, Anderson B. Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain. 2007;8(3):187-207. https://doi.org/10.1016/j.jpain.2006.11.008
  18. WHO contributes recommendations for improving palliative care services in the Russian Federation. Available at: http://www.euro.who.int/ru/countries/russian-federation/news/news/2017/04/who-contributes-recommendations-forimproving-palliative-care-services-in-the-russian-federation. Accessed04.07.2018

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.